Barriers and facilitators for the safe handling of antineoplastic drugs
- 6 October 2021
- journal article
- research article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 28 (8) , 1709-1721
Abstract
Introduction: Antineoplastic drugs are widely used in the treatment of cancer. However, some are known carcinogens and reproductive toxins, and incidental low-level exposure to workers is a health concern. CAREX Canada estimated that approximately 75,000 Canadians are exposed to antineoplastic drugs in workplace settings. While policies and guidelines on safe handling of antineoplastic drugs are available, evidence suggests that compliance is low. In this paper, we identify barriers and facilitators for safe handling of antineoplastic drugs in workplace settings. Methods: We utilized a unique method to study public policy which involved compiling policy levers, developing a logic model, conducting a literature review, and contextualizing data through a deliberative process with stakeholders to explore in-depth contextual factors and experiences for the safe handling of antineoplastic drugs. Results: The most common barriers identified in the literature were: poor training (46%), poor safety culture (41%), and inconsistent policies (36%). The most common facilitators were: adequate safety training (41%), leadership support (23%), and consistent policies (21%). Several of these factors are intertwined and while this means one barrier can cause other barriers, it also allows healthcare employers to mitigate these barriers by implementing small but meaningful changes in the workplace. Conclusion: The combination of barriers and facilitators identified in our review highlight the importance of creating work environments where safety is a priority for the safe handling of antineoplastic drugs. The results of this study will assist policy makers and managers in identifying gaps and enhancing strategies that reduce occupational exposure to antineoplastic drugs.Keywords
Funding Information
- Alberta Labour and Immigration (095245121)
- WorkSafeBC (RS2018-IG13)
This publication has 48 references indexed in Scilit:
- Factors Influencing Oncology Nurses' Use of Hazardous Drug Safe-Handling PrecautionsOncology Nursing Forum, 2012
- Leadership, psychological capital and safety research: Conceptual issues and future research questionsSafety Science, 2012
- Comprehensive systematic review of healthcare workers' perceptions of risk and use of coping strategies towards emerging respiratory infectious diseasesJBI Evidence Implementation, 2011
- Nurses' Use of Hazardous Drug-Handling Precautions and Awareness of National Safety GuidelinesOncology Nursing Forum, 2011
- Structures and processes of care in ambulatory oncology settings and nurse-reported exposure to chemotherapyBMJ Quality & Safety, 2011
- Safe Handling and Administration of Antineoplastic ChemotherapyJournal of Infusion Nursing, 2009
- Residual Hazard Assessment Related to Handling of Antineoplastic DrugsAnnals of the New York Academy of Sciences, 2006
- Realist review - a new method of systematic review designed for complex policy interventionsJournal of Health Services Research & Policy, 2005
- Chemotherapy-Handling Practices of Outpatient and Office-Based Oncology NursesOncology Nursing Forum, 2003
- Comparison of antineoplastic drug handling policies of hospitals with OSHA guidelines: a pilot study.American Journal of Public Health, 1990